BioCopy
discovery and development of biotherapeutic drugs using an automated, AI-assisted end-to-end platform and is developing next-generation biotherapeutic drug candidates
BioCopy has raised €18M across 2 funding rounds, most recently a Series A round in May 2026. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Basel, Switzerlandwww.biocopy.com ↗
Total raised
€18M
€17,793,254
Funding rounds
2
Investors
0
distinct backers
Active since
2025-03
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDBioCopy — funding by year — interactive chart.
Data table
| BioCopy — funding by year | |
|---|---|
| 2025 | €8.0M |
| 2026 | €9.8M |
Signals
Medium confidenceRaise-next likelihood40
base rate 44% for Series A
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▼ No recent equity round (debt-only or quiet)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-01 | Series A | €9.8M | — | View deal → |
| 2025-03-20 | Other | €8.0M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData